enVVeno Medical Corp (NVNO) is a Healthcare · Medical Devices company listed on NASDAQ. Price $8.99 (+2.24%), Market cap $0.01B, 52-week low–high $0.31 ~ $13.00.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was forme
Financial statements, price targets, institutional (13F) holdings and related news for enVVeno Medical Corp are updated in real time on BlackAll Trade.
enVVeno Medical Corp trades at $8.99 (+2.24%). Real-time quotes and charts are available on BlackAll Trade.
enVVeno Medical Corp has a market cap of about $0.01B.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the Unit